diabetes mellitus, type 2

Showing NaN - NaN of 183

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Diabetes, Type 2, Hypertension Trial in Houston (Motivational interviewing intervention arm)

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • Hypertension
  • Motivational interviewing intervention arm
  • Houston, Texas
    Omar Serna
Sep 27, 2021

Diabetes, Type 2 Trial in Houston (Neutral Protamine Hagedorn (NPH), Detemir insulin)

Completed
  • Diabetes Mellitus, Type 2
  • Neutral Protamine Hagedorn (NPH)
  • Detemir insulin
  • Houston, Texas
    University of Texas Health Science Center of Houston
Aug 20, 2021

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, , metformin)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +184 more
Jul 1, 2021

Diabetes, Diabetes, Type 2 Trial in Worldwide (Semaglutide, Placebo)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Andalusia, Alabama
  • +71 more
Jul 1, 2021

Diabetes, Type 2 Trial in Worldwide (vildagliptin + metformin, metformin)

Completed
  • Diabetes Mellitus, Type 2
  • Pine Bluff, Arkansas
  • +62 more
Dec 11, 2020

Diabetes, Type 2 Trial in Worldwide (Vildagliptin, Placebo)

Completed
  • Diabetes Mellitus, Type 2
  • Pell City, Alabama
  • +175 more
Dec 11, 2020

Diabetes, Type 2, Renal Insufficiency Trial in United States (vildagliptin, sitagliptin)

Completed
  • Diabetes Mellitus, Type 2
  • Renal Insufficiency
  • Mobile, Alabama
  • +86 more
Dec 11, 2020

Diabetes, Type 2 Trial in United States (vildagliptin, Sitagliptin)

Completed
  • Diabetes Mellitus, Type 2
  • Mobile, Alabama
  • +78 more
Dec 11, 2020

Diabetes, Type 2 Trial in Worldwide (Albiglutide, Insulin Glargine and Insulin Lispro)

Completed
  • Diabetes Mellitus, Type 2
  • Searcy, Arkansas
  • +157 more
Nov 13, 2020

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, )

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +81 more
Oct 26, 2020

Diabetes, Type 2, Heart Failure, Diastolic Trial in Houston (Exenatide)

Terminated
  • Diabetes Mellitus, Type 2
  • Heart Failure, Diastolic
  • Houston, Texas
    Baylor College of Medicine
Sep 2, 2020

Diabetes, Type 2 Trial in Worldwide (MEDI0382 low dose, MEDI0382 mid dose, MEDI0382 high dose)

Completed
  • Diabetes Mellitus, Type 2
  • MEDI0382 low dose
  • +4 more
  • Birmingham, Alabama
  • +118 more
Jul 31, 2020

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin glargine)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/liraglutide
  • insulin glargine
  • Glendale, Arizona
  • +87 more
Aug 10, 2020

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, alpha-glucosidase inhibitors, DPP-4 inhibitors)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +231 more
Jun 16, 2020

Diabetes, Type 2 Trial in United States (Dulaglutide Pen, Semaglutide Pen)

Completed
  • Diabetes Mellitus, Type 2
  • Dulaglutide Pen
  • Semaglutide Pen
  • Fresno, California
  • +13 more
Apr 10, 2020

Diabetes, Type 2 Trial in Worldwide (Ticagrelor 60 mg, Ticagrelor )

Completed
  • Diabetes Mellitus, Type 2
  • Ticagrelor 60 mg
  • Ticagrelor placebo
  • Alexander City, Alabama
  • +1241 more
Mar 4, 2020

Insulin Therapy in Type 2 Diabetes

Completed
  • Diabetes Mellitus, Type 2
    • Little Rock, Arkansas
    • +152 more
    Feb 25, 2020

    Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 2
    • Anniston, Alabama
    • +118 more
    Feb 14, 2020

    Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 2
    • Tuscumbia, Alabama
    • +116 more
    Feb 14, 2020

    Diabetes, Diabetes, Type 2 Trial in Worldwide (Semaglutide, Canagliflozin, Placebo (canagliflozin))

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 2
    • Anaheim, California
    • +118 more
    Jan 8, 2020

    Diabetes, Type 2 Trial in Worldwide (linagliptin, glimepiride, linagliptin )

    Completed
    • Diabetes Mellitus, Type 2
    • Athens, Alabama
    • +612 more
    Dec 19, 2019

    Diabetes, Type 2, Diabetic Nephropathy Trial in Worldwide (Canagliflozin, Placebo)

    Completed
    • Diabetes Mellitus, Type 2
    • Diabetic Nephropathy
    • Birmingham, Alabama
    • +592 more
    Dec 4, 2019

    Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin glargine)

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 2
    • insulin degludec/liraglutide
    • insulin glargine
    • Muscle Shoals, Alabama
    • +142 more
    Nov 8, 2019

    Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, Dulaglutide)

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 2
    • Tuscumbia, Alabama
    • +208 more
    Oct 2, 2019